22 filings from 4 registrants · 2012–2014 · latest filed May 5, 2014
Reported on its behalf
$1.7M
every LD-2 on file
Its own filed spend
$1.3M
lobbying for itself
Fees to outside firms
$463K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
21 filings
$1.7M on those filings
Pharmacy
PHA
2 filings
$70K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
H.R. 5651112th CongressFood and Drug Administration Reform Act of 20124 filingsthrough 2012
S. 3187112th CongressFood and Drug Administration Safety and Innovation Act4 filingsthrough 2012
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: viropharma-incorporated.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
spend on filings that named this issue
112th Congress
Generic Drug and Biosimilar User Fee Act of 2012
2 filingsthrough 2012
H.R. 4209112th CongressPatients' Access to Treatments Act of 20121 filingthrough 2012
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Covered position:
4 filingsthrough 2012
Amy TejralAvenue SolutionsCovered position: Legislative Director, Sen. Ben Nelson3 filingsthrough 2012
Tracy SpicerAvenue SolutionsCovered position: Dep. Chief of Staff, Sen. Edward M. Kennedy ; ; Political Director, Sen. Edward M. Kennedy ; ; Legislative Assistant, Sen. Edward M. Kennedy ; ; Special Assistant, Sen. Edward M. Kennedy ; ; Staff Assistant, Sen. Edward M. Kennedy3 filingsthrough 2012
Elizabeth Macdonald BarnettAvenue SolutionsCovered position: Legislative Assistant, Sen. Blanche Lincoln ; ; Speechwriter, Sen. Blanche Lincoln ; ; Legislative Correspondent, Sen. Blanche Lincoln ; ; Staff Assistant, Sen. Energy/Natural Resource Cmte3 filingsthrough 2012
Covered positions · 5 of 8 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
